Nuacht

It’s no secret that obesity is becoming an epidemic in the United  States. It’s estimated that by 2030, 50 percent of ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...
Dr Debra Marcos offers expert insight on why GLP-1 medications like Wegovy and Mounjaro are not only transforming the weight ...
Uncover the truth about GLP-1 weight loss drugs like Ozempic and Mounjaro. Learn how they work, who benefits most, potential risks, and why experts say they can be game-changing tools for fighting ...
GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...
By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...
ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the ...
The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed ...
People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...